United States· US:55154-3941_a3a10eba-ccb5-4e30-8c3c-c5b41c84c8a8

Solu-Medrol

A methylprednisolon, kombinationen product containing methylprednisolone sodium succinate, registered in United States by Cardinal Health 107, LLC. The same ATC class is registered in 6 of our 19 countries.

In shortageATC H02BX01Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSolu-MedrolATCH02BX01REGISTER NO.US:55154-3941_a3a10eb…PACKS LISTED1CHECKEDJune 3, 2026

Where it is registered

Methylprednisolon, kombinationen is registered in 6 of 19 countries.

Countries holding a registration under ATC H02BX01 (methylprednisolon, kombinationen), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose

Methylprednisolon, kombinationen · ATC H02BX01

6 / 19 countries

  • Canada
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
methylprednisolone sodium succinate
Manufacturer
Cardinal Health 107, LLC
Country
United States (US)
ATC code
H02BX01
ATC class
Methylprednisolon, Kombinationen
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    5515439415
    5 VIAL in 1 BAG (55154-3941-5) / 2 mL in 1 VIAL

Regulatory notes

UNII (FDA substance ID)
LEC9GKY20K
METHYLPREDNISOLONE SODIUM SUCCINATE
RxCUI 203189
Orange Book
N011856
APAPAPAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Methylprednisolone Acetate Injection

Same medicine, other countries

Methylprednisolon, kombinationen in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylprednisolon, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Solu-Medrol
  • Bulgaria · Метилпреднизолон Чайкафарма
  • Czechia · Solu-Medrol
  • Germany · Methylprednisolon Hikma, Metypred
  • Spain · Urbason
  • France · Methylprednisolone Hikma
  • United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
  • Hungary · Metilprednizolon Teva
  • Italy · Cortrium, Lisamethyle
  • Poland · Meprelon
  • Portugal · Metilprednisolona Hikma
  • Slovakia · Metylprednizolón Hikma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea85534f-f719-4059-94a7-0eabead2ea07
GET /v1/drugs/ea85534f-f719-4059-94a7-0eabead2ea07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "LEC9GKY20K",
    "rxcui": "203189",
    "inchikey": "FQISKWAFAHGMGT-SGJOWKDISA-M",
    "display_name": "METHYLPREDNISOLONE SODIUM SUCCINATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "spl_meta": {
    "8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9": {
      "match": "brand_token",
      "title": "SOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [A-S MEDICATION SOLUTIONS]",
      "spl_version": "33",
      "published_date": "2026-06-01"
    }
  },
  "productid": "55154-3941_a3a10eba-ccb5-4e30-8c3c-c5b41c84c8a8",
  "productndc": "55154-3941",
  "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
  "orange_book": {
    "appl_no": "011856",
    "products": [
      {
        "rs": true,
        "rld": true,
        "te_code": "AP",
        "strength": "EQ 40MG BASE/VIAL",
        "product_no": "003",
        "approval_date": "Approved Prior to Jan 1, 1982"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AP",
        "strength": "EQ 125MG BASE/VIAL",
        "product_no": "004",
        "approval_date": "Approved Prior to Jan 1, 1982"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AP",
        "strength": "EQ 500MG BASE/VIAL",
        "product_no": "005",
        "approval_date": "Approved Prior to Jan 1, 1982"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AP",
        "strength": "EQ 1GM BASE/VIAL",
        "product_no": "006",
        "approval_date": "Approved Prior to Jan 1, 1982"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AP",
        "strength": "EQ 2GM BASE/VIAL",
        "product_no": "007",
        "approval_date": "Feb 27, 1985"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "shortage_reason": "Methylprednisolone Acetate Injection",
  "shortage_status": "current",
  "proprietary_name": "Solu-Medrol",
  "active_ingred_unit": "mg/2mL",
  "application_number": "NDA011856",
  "marketing_category": "NDA",
  "nonproprietary_name": "methylprednisolone sodium succinate",
  "start_marketing_date": "19590402",
  "active_numerator_strength": "125"
}

See everything about methylprednisolon, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.